Health ❯Healthcare ❯Global Health
Treatment Accessibility Medical Aid Disruption PEPFAR USAID Programs Treatment Access
The twice-yearly injectable drug shows 96% effectiveness in reducing HIV risk, though affordability and resistance concerns remain.
